DW

Dede Willis

Life Sciences Entrepreneur

Boulder, Colorado

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • CEO and CoFounder

    2016

    Orbit Genomics is transforming complex disease diagnosis, treatment and prevention through early warning genomics. Our patent pending OrbiSeq™ platform analyzes novel genomic markers which uniquely reflect not only inherited predisposition to disease, but also risk acquired from lifestyle and environmental exposures. OrbiSeq can be applied to diagnose, treat and help prevent complex diseases including cancer, heart disease and neurological diseases.

  • Partner

    2003

    Ventac Partners is a life science company builder with offices in the US, EU and Asia. Ventac Partners has a strong track record of successfully launching new companies, fundraising, deal making and strategic consulting.

2016 - 2020

  • Business Mentor

    2016 - 2020

  • Member Board of Directors

    2016 - 2019

    Panion Animal Health AB ‘s aim is develop and commercialize the canine application of CombiGene AB’s technology for gene therapeutic treatment of drug refractory epilepsy. In addition, Panion plans to inlicense or acquire other, similar assets, i.e. the animal health applications of human health development projects or products. Panion was acquired by CombiGene in 2019.

  • Chief Operating Officer and CoFounder

    2009 - 2014

    Boulder Diagnostics Inc. is dedicated to bringing new diagnostic tests to market for diseases that are not reliably diagnosed today. We work with leading academic institutions and innovative companies to identify scientific breakthroughs that can deliver new, reliable diagnostic tests where today’s standard methods fail.

2010 - 2012

  • Vice President, Operations

    2010 - 2012

  • Vice President Operations

    2004 - 2007

  • Vice President

    1999 - 2002

  • Managing Director

    1999 - 2002

  • President & CEO

    1998 - 1999